亚洲象寄生虫驱虫效果报道

我园1984年11月从云南购入4只亚洲象,入园后经过系统的寄生虫检查,发现寄生有肝片形吸虫、象芬德吸虫、象线首钩虫、印度摩西德线虫、摩西德摩西德吸虫、镰状摩西德线虫、特拉文奎隆线虫和马蹄属线虫(大公象还寄生有裂体吸虫)。用药物先后治疗,发现左旋咪唑、阿苯唑对线虫驱虫良好,对肝片形吸虫稍差,对裂体吸虫无效;吡喹酮对裂体吸虫有效。以后又连续在3个月内用阿苯唑12—13mg/kg(每月两天),未见副反应,体况明显好转。现将结果简报如下:大公象:左旋咪唑(3mg/kg)、阿苯唑(4mg/kg)、吡喹酮(25mg/kg);驱出线虫4000条,前后盘吸虫1950条,2月后粪…     

巢式PCR检测食蟹猴和猕猴中SRV和SFV

目的利用巢式PCR方法检测圈养的食蟹猴（Macaca fascicularis）和猕猴（Macaca mulatta）中猴D型逆转录病毒（Simian Type D Retrovirus SRV）和猴泡沫病毒（Simian foamy virus SFV）。方法针对SRV-env和SFV-pol基因的保守区序列设计特异性外引物,然后再设计特异性内引物。将外引物扩增出的片段克隆到PJET1.2blunt载体中作为阳性对照,运用NCBI中BLAST软件比对测序结果。用巢式PCR方法分别检测食蟹猴和猕猴中SRV和SFV。结果发现食蟹猴中SFV感染率为65.2%,SRV感染率为9.5%,猕猴中SFV感染率为60.5%,SRV感染率为12.8%。结论圈养的食蟹猴和猕猴SFV的感染率均较高,SRV感染率很低。     

中老年食蟹猴群体自发型糖尿病的筛选

筛选440只中老年偏胖食蟹猴群体中自发糖尿病个体,并探讨食蟹猴群体中糖尿病粗筛的方法。以调查基础血糖值为基础,推断疑似糖尿病血糖值,后经OGTT(口服糖耐量)和尿检结果验证该血糖值是否准确。结果显示中老年偏胖食蟹猴群体血糖值为(3.88±0.98)mmol/L,其中56只食蟹猴血糖值大于5.0mmol/L,被初步定为糖尿病个体。这些个体全部糖耐量异常,且36只(69.23%)出现尿糖阳性,证明血糖值大于5.0mmol/L可作为本群体食蟹猴糖尿病的粗筛标准。由于针对中老年偏胖食蟹猴群体,患病率为12.72%(56/440),高于我国糖尿病患病率(9.7%)。虽然该实验的糖尿病血糖指标并不适用于所有食蟹猴群体,但是该筛选的流程简单快捷,对动物损伤小,可适用于大群体糖尿病的筛选。     

对羟基苯甲酸及其钠盐在小鼠和食蟹猴体内药代动力学及组织分布研究CSCD

前期研究表明对羟基苯甲酸(p-HBA)及其钠盐对羟基苯甲酸钠(s-HBA)均为治疗溃疡性结肠炎的潜在药物。本文研究p-HBA及s-HBA单次给药在正常小鼠体内药代动力学及组织分布特征,以及单次给药s-HBA后食蟹猴体内药代动力学特征。小鼠灌胃给予20 mg/kg的p-HBA和20、50、100 mg/kg的s-HBA,以及食蟹猴灌胃给予4、10、20 mg/kg的s-HBA。LC-MS/MS测定p-HBA和s-HBA在小鼠血浆和组织中的浓度,以及s-HBA在食蟹猴血浆中的浓度。所有血浆和组织均使用乙腈沉淀蛋白法处理。p-HBA及s-HBA在20 mg/kg的剂量下,血浆达峰时间T_(max)分别为0.08、0.08 h,达峰浓度C_(max)分别为20453.98、30683.33 ng/kg,时间曲线下面积AUC_(0-t)分别为7180.27、12008.42 ng·h/mL,半衰期t_(1/2)分别为0.57、0.59 h。s-HBA在小鼠和食蟹猴体内,C_(max)和AUC_(0-t)与剂量均呈良好的线性关系。分别给药p-HBA及s-HBA后,在小鼠的心,肝,脾,肺,肾,脑和结肠组织中均能检测到较高浓度的p-HBA。结果表明,p-HBA及s-HBA灌胃给药后在小鼠和食蟹猴体内吸收和消除均较快,在小鼠体内组织分布广泛,以肾和肝浓度最高,推测其对肾和肝有一定的靶向性,所有组织均无明显蓄积,提示安全性良好。     

猕猴、食蟹猴群中STLV-1病毒感染状况研究初报

[目的]摸清STLV-1感染现状,从而有效地降低STLV-1在猕猴、食蟹猴群中的的感染率。[方法]采用STLV-1ELISA法对猕猴、食蟹猴血清进行抗体检测。结果本中心送美国BioReliance公司的2455只出口猴血清,103份血清呈STLV-1抗体阳性,19份血清呈STLV-1抗体可疑,其余血清均为STLV-1抗体阴性。[结论]猕猴、食蟹猴群中STLV-1的平均感染率为4.97%,其中猕猴STLV-1感染率为2.7%,食蟹猴STLV-1感染率为5.4%,是猕猴STLV-1感染率的2倍;随着年龄的增长,猕猴(食蟹猴)STLV-1的感染率也随之升高。     

食蟹猴的基础血糖值调查

目的 调查圈养食蟹猴基础血糖值情况.方法 采用快速血糖仪对153只6～19岁雄性食蟹猴和87只6～24岁雌性食蟹猴的血糖进行测定.结果 不同性别的食蟹猴血糖值存在显著性差异(P＜0.05),其中雌性食蟹猴血糖平均值为4.09 mmol/L±1.03 mmol/L,雄性食蟹猴血糖平均值为3.32 mmol/L±0.59 mmol/L;不同年龄段的食蟹猴血糖值差异显著(P＜0.05),年龄大的食蟹猴血糖值比年龄小的食蟹猴血糖值整体较高;体重指数与基础血糖值之间无显著相关性.结论 食蟹猴基础血糖值与人类基础血糖值相比,水平较低;性别和年龄是影响食蟹猴血糖值的主要因素.食蟹猴基础血糖值调查为糖尿病动物模型的建立及其相关研究提供了有关血糖值的基础数据参考.     

猕猴的雌激素及骨物理指标、微量元素检测

目的 建立恒河猴和食蟹猴正常的雌激素及骨物理、微量元素指标.方法 选用恒河猴4只(雄性),平均年龄17.5岁.食蟹猴3只(雌性),平均年龄9岁.在测定骨物理指标后,用原子吸收光谱法测定Ca,Fe,Zn,Cu等元素的浓度;同时也检测血清中雌激素(E2)碱性磷酸酶(AKP)和羟脯氨酸的浓度.结果 正常恒河猴血清E2为288.0±143.9(pmol/L)、AKP为2.28±2.71(金氏单位/ml)、羟脯氨酸为10.45±2.60(ug/ml),Ca、Fe、Zn、Cu分别为5.01±1.20(g/g)、18.54±22.30(mg/g)、25.0±17.15(mg/g)、9.38±8.66(mg/g);食蟹猴血清E2为424.33±190.45(pmol/L)、AKP为9.45±2.76(金氏单位/ml)、羟脯氨酸为 16.91±3.00 (ug/ml),Ca、Fe、Zn、Cu分别为8.31±4.13(g/g)、24.32±17.20(mg/g)、50.97±33.63(mg/g)、24.31±17.40(mg/g).结论 恒河猴和食蟹猴的正常雌激素及骨物理、微量元素指标的建立,将为采用猕猴作为动物模型探讨骨质疏松的病因、发病机理提供参考依据.     

帕妥珠单抗生物类似药SMMU-27 静脉注射对食蟹猴的重复给药毒性探索研究

目的:观察帕妥珠单抗生物类似药SMMU-27四周静脉注射对食蟹猴的安全性。方法:20只健康食蟹猴按体重随机分为阳性对照组、SMMU-27低、中、高剂量组和辅料对照组,每组4只,雌雄各半。低、中、高剂量组剂量分别为15、150和450 mg/kg,阳性对照组给予150 mg/kg帕妥珠单抗(Pertuzumab),辅料对照组给予空白溶剂(0 mg/kg)。各组动物按相应体重慢速静脉注射给药,给药体积为15 m L/kg,给药速度约5 m L/min。每周给药1次,共给药4周,恢复期4周,期间进行各项毒理学指标检测。结果:一般症状结果显示给药期间与给药后,低、中、高剂量组和阳性对照组陆续有动物出现腹泻症状。高剂量组1只动物在d40时濒死剖解,其最早出现稀便,停药后腹泻状态也未见好转,生化指标显示在d28时碱性磷酸酶(Alkaline Phosphatase,ALP)升高,在d14和d40时尿素(Blood Urea,BU)升高,总蛋白(Total Protein,TP)、白蛋白(Albumin,ALB)降低。低、高剂量组和阳性对照组均有部分动物白细胞(White Blood Cell,WBC)给药后数值降低,各给药组在d14时及高剂量组和阳性对照组在d28时BU升高或有升高的趋势,恢复期时有恢复趋势。高剂量濒死动物骨髓检查发现核红细胞较多,各阶段粒细胞减少,出现较多裸核;病理检查发现肾脏可见散在多发的中度肾小管扩张,近曲小管上皮轻度变性。其余指标包括一般症状、体重、尿液、心电图、免疫学指标等未见明显与供试品相关的异常变化。结论:SMMU-27主要毒性靶部位是胃肠道(腹泻)、肾脏(血清BU升高)和血液系统(WBC下降),应与这些部位表达供试品结合的相关受体有关,属供试品的药理作用放大和延伸。因此本实验条件下食蟹猴的安全剂量(NOAEL)为150 mg/kg,致死剂量为450 mg/kg。SMMU-27与等剂量阳性对照药物毒性反应基本类似。     

雄性食蟹猴高敏C反应蛋白基础值及高脂膳食诱导后与血脂变化的关系研究”

本研究针对不同年龄段和高脂膳食诱导后雄性食蟹猴的高敏C反应蛋白(hs-CRP)的变化规律进行了研究。实验利用免疫比浊法对不同年龄段食蟹猴的后肢静脉血测定,并选择中年雄性食蟹猴饲喂高脂饲料,研究高脂膳食条件下hs-CRP值的变化及与总胆固醇的关系。结果显示老龄雄性食蟹猴的hs-CRP平均值高于中年和低龄食蟹猴(6.09 mg·L-1±2.06 mg·L-1VS.2.78 mg·L-1±1.48 mg·L-1&2.31 mg·L-1±1.52 mg·L-1),且差异均有统计学意义(P<0.05);老年雄性食蟹猴的hs-CRP值高于雄性群体均值(6.09±2.06 VS.3.19±2.16),差异也有统计学意义(P<0.05)。高脂膳食诱导后,食蟹猴总胆固醇(TC)含量显著升高(P<0.05),hs-CRP与对照组比较也有明显升高(P<0.05),提示hs-CRP可能与高脂含量有一定相关性,在心血管病动物实验研究中可作为辅助的预警指标。本研究确定了不同年龄段雄性食蟹猴的hs-CRP均值,且不同年龄段间hs-CRP存在差异;雄性食蟹猴经高脂膳食诱导后在总胆固醇含量升高的同时伴随hs-CRP水平的升高。本研究结果可为以灵长类动物为实验动物的心血管病相关研究提供基础数据。     

中国圈养食蟹猴TrimCyp基因频率

TRIM 5α在绝大部分的旧大陆猴中扮演抗逆转录病毒的角色,能够限制HIV-1的活性。TRIMCyp融合基因是继TRIM 5α后的另一个抗HIV-1因子研究热点。旧大陆猴的TRIMCyp融合基因是由CypA假基因cDNA序列以逆转录转座的方式插入至TRIM5基因的3’非翻译区形成,而且TRIMCyp融合基因在不同灵长类动物中具有地域、基因频率、基因型以及抗逆转病毒效应的差异。虽然食蟹猴TRIMCyp基因的频率在东南亚几个国家或地区已经被初步调查,但是,中国大陆食蟹猴养殖场的TRIMCyp基因频率还没有明确阐明。该研究对中国5个省11个养殖场共1594个食蟹猴(Macaca fascicularis)繁殖种群随机样本的TRIMCyp基因频率进行了筛查研究,发现各场频率略有差异,从7.65%～19.79%不等,显著低于已报道的菲律宾、马来西亚和印度尼西亚来源食蟹猴的TRIMCyp基因频率(34.85%~100%)。该原因可能是由于后者是建立于1978年的封闭群。对带有TRIMCyp融合基因的个体CypA测序发现带有NE单倍型的食蟹猴个体很少,NE单倍型频率(4.93%)显著低于东南亚三个国家食蟹猴的NE单倍型频率(11.1%～14.3%)纯合子。该研究为进一步开展食蟹猴HIV-1动物模型和发病机制提供了基础信息。     

Mitigation of caffeine-induced teratogenicity in mice by prior chronic caffeine ingestion.

Pregnant A/J female mice, which had drunk tap water or a 0.05% caffeine solution for 8-19 weeks after weaning, were each injected sc with 150 or 250 mg/kg caffeine once on day 13 of gestation. After 150 mg/kg caffeine the frequencies at term of fetal death, external malformation, and subcutaneous hematomas were significantly lower in the caffeine- than water-drinking group. After 250 mg/kg caffeine the frequency of fetal death but not of malformations and hematomas was lower in the group with caffeine pretreatment. These findings were explained by assuming that long-term ingestion of caffeine induced and increased rate of degradation of caffeine administered during pregnancy.     

Anesthesia for prairie dogs

The combination of 20 mg xylazine/kg of body weight and 100-150 mg ketamine/kg of body weight provided satisfactory levels of anesthesia in 63 prairie dogs, and the combination was tolerated well with a mortality rate of 3.2%.     

Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices

The main objective of the present study was to evaluate the reduction in halofantrine (Hf) toxicity, an antimalarial drug frequently associated with QT interval prolongation in electrocardiogram, by its entrapment in poly-epsilon-caprolactone nanocapsules (NC). The acute lethal dose (LD(100)) of Hf.HCl experimentally observed was 200 mg/kg whereas the calculated LD(50) was 154 mg/kg. In contrast, the LD(100) for Hf-NC was 300 mg/kg with a longer mean time to death than Hf.HCl. The calculated LD(50) was 249 mg/kg for Hf-NC. The Hf entrapped in PCL NC presented a greater efficacy than PLA-PEG NC and than Hf solution in P. berghei-infected mice at 1 mg/kg. The cardiovascular parameters, ECG and arterial blood pressure, were evaluated in anaesthetized Wistar rats after the IV administration of a single, especially high dose (100 and 150 mg/kg) of halofantrine base loaded-nanocapsules (Hf-NC) or halofantrine chlorhydrate (Hf.HCl) solution. It was observed that Hf solution caused prolongation of the QT and PR intervals of the ECG; however, this effect was significantly (P<0.001) reduced when Hf was administered entrapped in nanocapsules. The treatment with Hf.HCl induced a pronounced bradycardia and severe hypotension leading to death. The effect of Hf-NC upon heart rate was reduced from 58 to 75% for 100 and 150 mg/kg, respectively, when compared with Hf.HCl solution. These findings show that the encapsulation of halofantrine reduces the QT interval prolongation of ECG in rats and suggest that a modification of drug distribution was possible by using nanocapsules. Hf encapsulation was the main factor responsible for the significant reduction in cardiac toxicity observed.     

两面针提取物(S-O)对小鼠镇痛、抗炎和止血作用的研究

本研究对两面针根的提取物S-O进行了镇痛、止血和抗炎药理实验,每种作用选用两种实验方法来评价。镇痛作用采用热板法和扭体法。热板法实验显示,S-O在150mg/kg剂量时,小鼠痛阈值明显提高（P〈0．01）;扭体法实验显示,S-O在150mg/kg剂量为时,对冰醋酸致痛的小鼠扭体反应次数减少了70．96％（P〈0．01）。抗炎实验采用二甲苯致小鼠耳廓肿胀法及腹腔染料渗出法。二甲苯致炎剂实验表明,S-O在150mg/kg剂量时,对二甲苯所致小鼠耳廓肿胀有明显抑制作用,抑制率为63．45％（P〈0．01）;冰醋酸所致的腹腔毛细血管通透性实验中,S-O在150mg/kg和75mg/kg两个剂量组时,对小鼠的抗炎效果分别为52．94％（P〈0．01）和52．00％（P〈0．01）。止血实验采用毛细玻璃管法和载玻片法。毛细玻璃管实验表明S-O在150mg/kg和75mg/kg两个剂量时,凝血时间明显缩短（P〈0．01）;载玻片实验表明S-O在150mg/kg剂量时,凝血时间明显缩短（P〈0．01）。总之,两面针中提取物S-O对小鼠具有显著的镇痛、止血和抗炎作用。     

两面针提取物(S0)对小鼠镇痛、抗炎和止血作用的研究(英文)

本研究对两面针根的提取物S0进行了镇痛、止血和抗炎药理实验,每种作用选用两种实验方法来评价。镇痛作用采用热板法和扭体法。热板法实验显示,S0在150mg/kg剂量时,小鼠痛阈值明显提高(P<0.01);扭体法实验显示,S0在150mg/kg剂量为时,对冰醋酸致痛的小鼠扭体反应次数减少了70.96%(P<0.01)。抗炎实验采用二甲苯致小鼠耳廓肿胀法及腹腔染料渗出法。二甲苯致炎剂实验表明,S0在150mg/kg剂量时,对二甲苯所致小鼠耳廓肿胀有明显抑制作用,抑制率为63.45%(P<0.01);冰醋酸所致的腹腔毛细血管通透性实验中,S0在150mg/kg和75mg/kg两个剂量组时,对小鼠的抗炎效果分别为52.94%(P<0.01)和52.00%(P<0.01)。止血实验采用毛细玻璃管法和载玻片法。毛细玻璃管实验表明S0在150mg/kg和75mg/kg两个剂量时,凝血时间明显缩短(P<0.01);载玻片实验表明S0在150mg/kg剂量时,凝血时间明显缩短(P<0.01)。总之,两面针中提取物S0对小鼠具有显著的镇痛、止血和抗炎作用。     

Toxoplasma encephalitis: influence of the vehicle on the efficacy of different doses of 2',3'-dideoxyinosine in mice

In this study we investigated the effect of the antiretroviral molecule 2',3'-dideoxyinosine (Videx) against cerebral cysts in a murine model of toxoplasmic encephalitis caused by a wild cystic strain of Toxoplasma gondii. The role of the vehicle was also studied. Three doses were used: 50, 100 and 150 mg/kg of body weight/day. The doses of 50 and 150 mg/kg were prepared by dissolving pure 2',3'-dideoxyinosine powder in Maalox suspension before gavaging the mice; the dose of 100 mg/kg was prepared by grinding tablets of Videx that were suspended in water. A decrease in the number of cysts and a morphological modification of them were noted from day 15 with the lowest dose. The most important decrease could be observed with the dose of 100 mg/kg/d. After 30 days of treatment with this dose, 65% of the cysts were destroyed compared to controls. For the doses of 50 and 150 mg/kg/d prepared with Maalox, 36% and 51% of the cysts were destroyed respectively. So ddI has an effect on the cerebral cysts of T. gondii even at a low dose. The galenic formulation influences its action since the doses prepared with Maalox were less efficient than those prepared from ground tablets.     

Effect of parenterally injected benzimidazole compounds on Echinococcus multilocularis and Taenia crassiceps metacestodes in laboratory animals.

In mice infected with metacestodes of Taenia crassiceps, the following compounds were at least partially effective when injected intraperitoneally at the dosage indicated: cambendazole (500 mg/kg), mebendazole (6.25 mg/kg), oxibendazole (500 mg/kg), 5-benzamido-2(4-thiazolyl)benzimidazole (500 mg/kg), 2-carboethoxyamino benzimidazole (125 mg/kg), and 2-carbomethoxyamino benzimidazole (500 mg/kg). The following were inactive at the dosage indicated: parbendazole (500 mg/kg), thiabendazole (1,000 mg/kg), and fenbendazole (1,000 mg/kg). Mebendazole, which showed some activity at 6.25 mg/kg, was highly active as a single intraperitoneal dose at 25 mg/kg. When injected subcutaneously, mebendazole was much less active than when given intraperitoneally. In mice infected with metacestodes of Echinococcus multilocularis, intraperitoneal injection of mebendazole at 75 to 150 mg/kg, daily for 3 days, was highly effective (95 to 100% reduction in cyst mass). In contrast, oral administration at 1,000 mg/kg, daily for 3 days, was only partially effective. The drug was also effective when given intraperitoneally to infected cotton rats. A water-soluble benzimidazole, carboxymethyleneamino cambendazole, was approximately 50% effective in mice when injected daily for 3 days at a dosage of 75 or 150 mg/kg. The results suggest that, in metacestode infections of medical importance, it may be possible to kill the parasite by delivering a drug to its immediate vicinity, and so to reduce the required dosage with respect to the host.     

Single dose oral treatment in urinary schistosomiasis: a double blind trial.

A double blind trial of three oral preparations given in single doses for the treatment of Schistosoma haematobium infection was carried out in schoolchildren; selection was biased towards those who excreted large quantities of eggs. Praziquantel 40 mg/kg was the most effective drug giving a greater than 97% reduction in egg output six months after treatment; combined treatment with niridazole 25 mg/kg and metrifonate 10 mg/kg gave a reduction of greater than 92% and metrifonate 10 mg/kg alone a reduction of greater than 86%. Fewer children continued to have moderate to heavy infections (excretion greater than 124 ova/10 ml urine) six months after treatment with praziquantel (5%) and the combined regimen (7%) than with metrifonate (16%). Though our findings show that praziquantel appears to be the most effective and convenient drug available for individuals with S haematobium infection, the combined regimen is a cheaper alternative for treatment where cost is important and parasitological cure not an essential objective.     

不同剂量博莱霉素诱导小鼠肺纤维化的差异及动态变化

目的探讨博来霉素诱导小鼠肺纤维化最佳剂量和方法。方法 126只8周龄雄性ICR小鼠,随机分成一次性大剂量模型和多次小剂量模型。一次性大剂量模型分为200 mg/(kg.bw)BLM组、150 mg/(kg.bw)BLM组、100 mg/(kg.bw)BLM组及阴性对照组(DN组),每组18只,分别经尾静脉一次性注射BLM 200、150、100mg/(kg.bw)及生理盐水10 mL/(kg.bw),各组分别于第7、14、21天各处死6只。多次小剂量模型分为每日10 mg/(kg.bw)BLM组及阴性对照组(N组),分别经尾静脉注射BLM 10 mg/(kg.bw)及生理盐水10 mL/(kg.bw),每天1次,连续注射14 d,两组分别于第14、21、28天各处死6只。留取肺组织,观察肺组织病理改变,检测Ⅲ型胶原的含量,观察小鼠体重及生存率。结果①在一次性大剂量模型中,BLM各剂量组肺泡炎症评分及肺纤维化评分与正常组相比,除100 mg/(kg.bw)BLM组和150 mg/(kg.bw)BLM组在第7天的模型差异无显著性外(P>0.05),其余各组差异均有显著性(P<0.05);各个剂量组Ⅲ型胶原的表达面积与正常组相比,除100 mg/(kg.bw)BLM组在第7天的模型差异无显著性外(P>0.05),其余各组均较正常组高(P<0.05),各个剂量组分别在第21天达到高峰,以200 mg/(kg.bw)BLM组第21天组Ⅲ型胶原的表达面积最高;该模型小鼠各剂量组死亡率为0。②在多次小剂量模型中,各组的肺泡炎症与肺纤维化程度与正常组相比差异均有显著性(P<0.05);各组Ⅲ型胶原的表达也均高于正常组(P<0.05),且随着时间的延长呈进行性增加,在第28天达到高峰;该模型小鼠共死亡11只,死亡率为30.56%。结论在本实验中,以尾静脉一次性注射BLM 200 mg/(kg.bw)后第21天诱导建立的ICR小鼠肺纤维化模型成模最好,其小鼠死亡率低,操作简单,有效安全方便的特点使之有希望成为一种复制肺纤维化的理想模型。     

卫星灵芝液体发酵富集硒锌的研究

研究不同浓度的硒、锌对卫星灵芝菌丝体生长的影响,初步探讨卫星灵芝菌丝体生物富集硒、锌的效应。采用平板培养法及液体发酵法研究锌、硒对卫星灵芝菌丝体生长的影响及富集效应。培养基中不同浓度的亚硒酸钠对菌丝体生长均具有不同程度的抑制作用,但灵芝菌丝体的富硒量随着硒浓度的增加而提高,当亚硒酸钠浓度为40 mg/L时,菌丝体中的生物量、富硒量及富硒转化率最高,分别为1.54%、2 131.55 mg/kg、32.91%;培养基中硫酸锌浓度低于150 mg/L的范围内对卫星灵芝菌丝体生长有明显的促进作用,硫酸锌浓度为60 mg/L时菌丝体中的锌含量和富锌转化率最高,分别为1 142.91 mg/kg、1.76%。培养基中同时添加40 mg/L的亚硒酸钠和60 mg/L硫酸锌,菌丝体生长量1.60%,富硒量301.85 mg/kg,富硒率4.84%;富锌量为540.41 mg/kg,富锌率为5.72%。